
### [MONDO:0009637](http://purl.obolibrary.org/obo/MONDO_0009637)
**Label:** mitochondrial myopathy

**Subclasses:** [MONDO:0012241](http://purl.obolibrary.org/obo/MONDO_0012241) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 3), [MONDO:0019016](http://purl.obolibrary.org/obo/MONDO_0019016) (maternally-inherited progressive external ophthalmoplegia), [MONDO:0010782](http://purl.obolibrary.org/obo/MONDO_0010782) (myopathy, lactic acidosis, and sideroblastic anemia 3), [MONDO:0018002](http://purl.obolibrary.org/obo/MONDO_0018002) (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), [MONDO:0014220](http://purl.obolibrary.org/obo/MONDO_0014220) (myopathy due to Myoadenylate deaminase deficiency), [MONDO:0017575](http://purl.obolibrary.org/obo/MONDO_0017575) (mitochondrial neurogastrointestinal encephalomyopathy), [MONDO:0010780](http://purl.obolibrary.org/obo/MONDO_0010780) (mitochondrial myopathy with reversible cytochrome c oxidase deficiency), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0014062](http://purl.obolibrary.org/obo/MONDO_0014062) (mitochondrial DNA deletion syndrome with progressive myopathy), [MONDO:0009638](http://purl.obolibrary.org/obo/MONDO_0009638) (mitochondrial myopathy with a defect 1N Mitochondrial-protein transport), [MONDO:0016809](http://purl.obolibrary.org/obo/MONDO_0016809) (spinocerebellar ataxia with epilepsy), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0010789](http://purl.obolibrary.org/obo/MONDO_0010789) (MELAS syndrome), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0013116](http://purl.obolibrary.org/obo/MONDO_0013116) (congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome), [MONDO:0010787](http://purl.obolibrary.org/obo/MONDO_0010787) (Kearns-Sayre syndrome), [MONDO:0016825](http://purl.obolibrary.org/obo/MONDO_0016825) (mitochondrial myopathy-lactic acidosis-deafness syndrome), [MONDO:0013117](http://purl.obolibrary.org/obo/MONDO_0013117) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 5), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0012172](http://purl.obolibrary.org/obo/MONDO_0012172) (mitochondrial trifunctional protein deficiency), [MONDO:0010792](http://purl.obolibrary.org/obo/MONDO_0010792) (lethal infantile mitochondrial myopathy), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0010790](http://purl.obolibrary.org/obo/MONDO_0010790) (MERRF syndrome), [MONDO:0009640](http://purl.obolibrary.org/obo/MONDO_0009640) (mitochondrial complex i deficiency), [MONDO:0009783](http://purl.obolibrary.org/obo/MONDO_0009783) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 1), [MONDO:0009641](http://purl.obolibrary.org/obo/MONDO_0009641) (mitochondrial complex II deficiency), [MONDO:0009529](http://purl.obolibrary.org/obo/MONDO_0009529) (pyruvate dehydrogenase E3 deficiency), [MONDO:0012238](http://purl.obolibrary.org/obo/MONDO_0012238) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 2), [MONDO:0013307](http://purl.obolibrary.org/obo/MONDO_0013307) (myopathy, lactic acidosis, and sideroblastic anemia 2), [MONDO:0014898](http://purl.obolibrary.org/obo/MONDO_0014898) (progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3; PEOB3), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0014656](http://purl.obolibrary.org/obo/MONDO_0014656) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 2), [MONDO:0014899](http://purl.obolibrary.org/obo/MONDO_0014899) (adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency), [MONDO:0012415](http://purl.obolibrary.org/obo/MONDO_0012415) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 4), 

**Corr. equiv. classes:** [OMIM:600462](http://purl.obolibrary.org/obo/OMIM_600462), [OMIM:251945](http://purl.obolibrary.org/obo/OMIM_251945), [OMIM:157640](http://purl.obolibrary.org/obo/OMIM_157640), [Orphanet:480](http://www.orpha.net/ORDO/Orphanet_480), [OMIM:607459](http://purl.obolibrary.org/obo/OMIM_607459), [Orphanet:254864](http://www.orpha.net/ORDO/Orphanet_254864), [OMIM:545000](http://purl.obolibrary.org/obo/OMIM_545000), [OMIM:617069](http://purl.obolibrary.org/obo/OMIM_617069), [OMIM:500011](http://purl.obolibrary.org/obo/OMIM_500011), [OMIM:302060](http://purl.obolibrary.org/obo/OMIM_302060), [Orphanet:551](http://www.orpha.net/ORDO/Orphanet_551), [Orphanet:111](http://www.orpha.net/ORDO/Orphanet_111), [Orphanet:550](http://www.orpha.net/ORDO/Orphanet_550), [Orphanet:45](http://www.orpha.net/ORDO/Orphanet_45), [OMIM:500009](http://purl.obolibrary.org/obo/OMIM_500009), [Orphanet:254892](http://www.orpha.net/ORDO/Orphanet_254892), [OMIM:617070](http://purl.obolibrary.org/obo/OMIM_617070), [Orphanet:2609](http://www.orpha.net/ORDO/Orphanet_2609), [Orphanet:254857](http://www.orpha.net/ORDO/Orphanet_254857), [Orphanet:329336](http://www.orpha.net/ORDO/Orphanet_329336), [OMIM:613076](http://purl.obolibrary.org/obo/OMIM_613076), [OMIM:613077](http://purl.obolibrary.org/obo/OMIM_613077), [Orphanet:746](http://www.orpha.net/ORDO/Orphanet_746), [OMIM:258450](http://purl.obolibrary.org/obo/OMIM_258450), [Orphanet:663](http://www.orpha.net/ORDO/Orphanet_663), [Orphanet:254881](http://www.orpha.net/ORDO/Orphanet_254881), [Orphanet:254886](http://www.orpha.net/ORDO/Orphanet_254886), [OMIM:616479](http://purl.obolibrary.org/obo/OMIM_616479), [OMIM:613561](http://purl.obolibrary.org/obo/OMIM_613561), [OMIM:610131](http://purl.obolibrary.org/obo/OMIM_610131), [Orphanet:352470](http://www.orpha.net/ORDO/Orphanet_352470), [OMIM:612874](http://purl.obolibrary.org/obo/OMIM_612874), [OMIM:609015](http://purl.obolibrary.org/obo/OMIM_609015), [Orphanet:298](http://www.orpha.net/ORDO/Orphanet_298), [OMIM:540000](http://purl.obolibrary.org/obo/OMIM_540000), [OMIM:246900](http://purl.obolibrary.org/obo/OMIM_246900), [Orphanet:329314](http://www.orpha.net/ORDO/Orphanet_329314), [OMIM:609283](http://purl.obolibrary.org/obo/OMIM_609283), [OMIM:530000](http://purl.obolibrary.org/obo/OMIM_530000), [OMIM:615511](http://purl.obolibrary.org/obo/OMIM_615511), [OMIM:615156](http://purl.obolibrary.org/obo/OMIM_615156), [OMIM:551000](http://purl.obolibrary.org/obo/OMIM_551000), [Orphanet:3208](http://www.orpha.net/ORDO/Orphanet_3208), [Orphanet:2394](http://www.orpha.net/ORDO/Orphanet_2394), [Orphanet:70595](http://www.orpha.net/ORDO/Orphanet_70595), [Orphanet:330054](http://www.orpha.net/ORDO/Orphanet_330054), [Orphanet:2597](http://www.orpha.net/ORDO/Orphanet_2597), [OMIM:252010](http://purl.obolibrary.org/obo/OMIM_252010), [Orphanet:2598](http://www.orpha.net/ORDO/Orphanet_2598), [OMIM:609286](http://purl.obolibrary.org/obo/OMIM_609286), [OMIM:252011](http://purl.obolibrary.org/obo/OMIM_252011), 

**Class expressions from DL-Learner:**

- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 56.34%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 55.08%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 54.55%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 54.23%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) 54.10%
- [HP:0001941](http://purl.obolibrary.org/obo/HP_0001941) (Acidosis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 54.10%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 53.61%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 53.44%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 53.06%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 53.06%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 53.06%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 53.06%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 53.06%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 53.06%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 52.73%


